211 related articles for article (PubMed ID: 11724204)
1. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study.
Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Fluckiger L; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; van Roon AM; Smit AJ
Am J Hypertens; 2001 Nov; 14(11 Pt 1):1083-9. PubMed ID: 11724204
[TBL] [Abstract][Full Text] [Related]
2. Less adrenergic response to mental task during verapamil compared to amlodipine treatment in hypertensive subjects.
Sevre K; Lefrandt JD; Eide I; Smit AJ; Rostrup M
Blood Press; 2001; 10(2):111-5. PubMed ID: 11467760
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension.
Binggeli C; Corti R; Sudano I; Luscher TF; Noll G
Hypertension; 2002 Apr; 39(4):892-6. PubMed ID: 11967245
[TBL] [Abstract][Full Text] [Related]
4. Autonomic nervous system adjustment (ANSA) in patients with hypertension treated with enalapril.
Milovanovic B; Trifunovic D; Djuric D
Acta Physiol Hung; 2011 Mar; 98(1):71-84. PubMed ID: 21388933
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of azelnidipine and amlodipine on sympathetic nerve activity in patients with primary hypertension.
Inomata J; Murai H; Kaneko S; Hamaoka T; Ikeda T; Kobayashi D; Usui S; Furusho H; Sugiyama Y; Takata S; Takamura M
J Hypertens; 2014 Sep; 32(9):1898-904. PubMed ID: 24979307
[TBL] [Abstract][Full Text] [Related]
6. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.
Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; Smit AJ
Br J Clin Pharmacol; 2001 Dec; 52(6):687-92. PubMed ID: 11736880
[TBL] [Abstract][Full Text] [Related]
8. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
[TBL] [Abstract][Full Text] [Related]
9. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189
[TBL] [Abstract][Full Text] [Related]
10. The significance of amlodipine on autonomic nervous system adjustment (ANSA method): a new approach in the treatment of hypertension.
Milovanović B; Trifunović D; Milićević N; Vasić K; Krotin M
Srp Arh Celok Lek; 2009; 137(7-8):371-8. PubMed ID: 19764590
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension.
Kailasam MT; Parmer RJ; Cervenka JH; Wu RA; Ziegler MG; Kennedy BP; Adegbile IA; O'Connor DT
Hypertension; 1995 Jul; 26(1):143-9. PubMed ID: 7607717
[TBL] [Abstract][Full Text] [Related]
12. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
13. Effects of azelnidipine and amlodipine on exercise-induced sympathoexcitation assessed by pupillometry in hypertensive patients.
Koike Y; Kawabe T; Nishihara K; Iwane N; Hano T
Hypertens Res; 2016 Dec; 39(12):863-867. PubMed ID: 27439493
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive treatment with verapamil and amlodipine. Their effect on the functional autonomic and cardiovascular stress responses.
Nazzaro P; Manzari M; Merlo M; Triggiani R; Scarano AM; Lasciarrea A; Pirrelli A
Eur Heart J; 1995 Sep; 16(9):1277-84. PubMed ID: 8582392
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of amlodipine monotherapy and combination therapy with betaxolol on cardiac autonomic nervous activity and health-related quality of life in patients with poorly controlled hypertension.
Takase B; Takeishi Y; Hirai T; Lee JD; Uzui H; Senda S; Miwa K; Hiraoka Y; Kinugawa T; Hosokawa R; Fujita M
Circ J; 2008 May; 72(5):764-9. PubMed ID: 18441457
[TBL] [Abstract][Full Text] [Related]
16. Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients.
Minami J; Ishimitsu T; Kawano Y; Matsuoka H
Clin Exp Pharmacol Physiol; 1998; 25(7-8):572-6. PubMed ID: 9673431
[TBL] [Abstract][Full Text] [Related]
17. Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release.
Leenen FH; Coletta E; White R
J Hypertens; 2006 Jan; 24(1):177-84. PubMed ID: 16331116
[TBL] [Abstract][Full Text] [Related]
18. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
Fogari R; Zoppi A; Corradi L; Preti P; Malalamani GD; Mugellini A
J Hypertens; 2000 Dec; 18(12):1871-5. PubMed ID: 11132613
[TBL] [Abstract][Full Text] [Related]
19. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.
Minami J; Kawano Y; Makino Y; Matsuoka H; Takishita S
Br J Clin Pharmacol; 2000 Dec; 50(6):615-20. PubMed ID: 11136301
[TBL] [Abstract][Full Text] [Related]
20. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.
Karas M; Lacourcière Y; LeBlanc AR; Nadeau R; Dubé B; Florescu M; Lamarre-Cliche M; Poirier L; Larochelle P; de Champlain J
J Hypertens; 2005 Jun; 23(6):1251-60. PubMed ID: 15894902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
